Gary Goldenberg

This profile gathers the share dealings of Gary Goldenberg in Verrica Pharmaceuticals Inc. Over a trading history stretching from 5 July 2022 to 26 August 2024, the count stands at 8 filings.

Market trades split into 1 purchase (€49k) and 3 sales (€159k). Netting one side against the other leaves €110k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 4 share grants.

The newest entry dates from 6 February 2025: a share grant, in Verrica Pharmaceuticals Inc. The most recent open-market purchase was published on 5 July 2022, 1,566 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.